Kristleifur Kristjansson
Plus aucun poste en cours
Historique de carrière de Kristleifur Kristjansson
Anciens postes connus de Kristleifur Kristjansson
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| EMBLA MEDICAL HF. | Chief Tech/Sci/R&D Officer | 01/01/2012 | 01/07/2022 |
deCODE genetics, Inc.
 deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | Founder | 01/01/1995 | 01/01/2012 |
| Corporate Officer/Principal | 01/01/1995 | 01/01/2012 | |
| Skraeda ehf | Founder | - | - |
Formation de Kristleifur Kristjansson
| University of Iceland | Doctorate Degree |
Statistiques
Internationale
| Islande | 5 |
Opérationnelle
| Founder | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EMBLA MEDICAL HF. | Health Technology |
| Entreprise privées | 2 |
|---|---|
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | Health Technology |
| Skraeda ehf |
- Bourse
- Insiders
- Kristleifur Kristjansson
- Expérience
